Close Menu

NEW YORK – Japanese chemical products firm Denka said today it has expanded its strategic partnership with Taipei, Taiwan-based PlexBio with a private equity investment of NTD$245 million ($24 million).

As a result, Denka now owns 33.4 percent of PlexBio's shares. PlexBio will use the financing for operations and product development. Both firms' goals are to advance their positions in the molecular diagnostics space, drive growth, and allow Denka to expand into new markets, they said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.